HAPVIDA (HAPV3) Main Indicators
Basic Data - HAPV3
| Company | HAPVIDA |
| Corporate Name | HAPVIDA PARTICIPACOES E INVESTIMENTOS SA |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Participação. como sócia ou acionista. em outras empresas. predominantemente de assistência médica. bem como a realização de investimentos diretos e a exploração de atividades de prestação de serviços |
| Share | HAPV3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 3.02 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 340.45 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IBOVESPA, IBRA, IBRX, IBRX50, ICON, IGC, IGCT, IGNM, ITAG, IVBX, MLCX |
| Updated 11/21/2024 | |
Relative Prices - HAPV3
| Price/Earnings | -42.72 |
| Price/SBV | 0.47 |
| Price/Net Sales | 0.79 |
| Price/CFO | 8.47 |
| Price/FCF | 8.96 |
| Price/Total Assets | 0.31 |
| Price/EBIT | 20.54 |
| Price/Working Capital | 8.47 |
| Price/NCAV | -1.01 |
| EV/EBIT | 30.09 |
| EV/EBITDA | 15.85 |
| EV/Net Sales | 1.16 |
| EV/CFO | 12.40 |
| EV/FCF | 13.13 |
| EV/Total Assets | 0.45 |
| Company Market Cap | R$ 22.77 B |
| Enterprise Value | R$ 33.35 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 3.02 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - HAPV3
| Net Revenue | R$ 28.70 B |
| Gross Result | R$ 3.28 B |
| EBIT | R$ 1.11 B |
| Depreciation and Amortization | - R$ 995.41 M |
| EBITDA | R$ 2.10 B |
| Net Profit | - R$ 532.93 M |
| Net Profit/Share | - R$ 0.07 |
| Updated 11/12/2024 | |
| Net Revenue | R$ 7.73 B |
| Gross Result | R$ 1.02 B |
| EBIT | R$ 253.07 M |
| Depreciation and Amortization | - R$ 651.98 M |
| EBITDA | R$ 905.05 M |
| Net Profit | - R$ 81.26 M |
| Profit/Share | - R$ 0.01 |
| Updated 11/12/2024 | |
Price and Volume Behavior - HAPV3
| Lowest Price 52 weeks | R$ 2.95 |
| Highest Price 52 weeks | R$ 4.69 |
| Variation 2024 | -29.60% |
| Variation 1 year | -34.91% |
| Variation 2 years(total) | -46.83% |
| Variation 2 years(yearly) | -27.02% |
| Variation 3 years(total) | -77.09% |
| Variation 3 years(yearly) | -38.79% |
| Variation 4 years(total) | -78.73% |
| Variation 4 years(yearly) | -32.09% |
| Variation 5 years(total) | -71.61% |
| Variation 5 years(yearly) | -22.24% |
| Average Daily Volume (3 months) | R$ 252.76 M |
| Updated 11/21/2024 | |
Returns and Margins - HAPV3
| Return on Initial Tangible Capital | 4.39% |
| Return on Initial Invested Capital | 1.23% |
| Pre-Tax Return on Initial Tangible Capital | 6.66% |
| Pre-Tax Return on Initial Invested Capital | 1.87% |
| Return on Initial Shareholder´s Equity | -1.09% |
| Return on Initial Asset | -0.71% |
| Gross Margin | 11.42% |
| Net Margin | -1.86% |
| EBIT Margin | 3.86% |
| EBITDA Margin | 7.33% |
| Initial Asset Turnover | 0.38 |
| Financial Leverage | 1.52 |
| Liabilities/Net Worth | 0.52 |
| Net Debt/EBITDA | 5.03 |
| Updated 11/12/2024 | |
Balance Sheet - HAPV3
| Cash and Cash Equivalents | R$ 488.84 M |
| Total Assets | R$ 73.87 B |
| Short-Term Debt | R$ 602.56 M |
| Long-Term Debt | R$ 10.47 B |
| Gross Debt | R$ 11.07 B |
| Net Debt | R$ 10.58 B |
| Shareholder´s Equity | R$ 48.69 B |
| Share Book Value | R$ 6.46 |
| Common Shares | 7,539,463,263 |
| Preferred Shares | 0 |
| Total | 7,539,463,263 |
| Common Shares in Treasury | 45,073,213 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 45,073,213 |
| Common Shares (Except Treasury) | 7,494,390,050 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 7,494,390,050 |
| Updated 11/12/2024 | |
Cash Flow - HAPV3
| Operating Cash Flow | R$ 2.69 B |
| Cash Flow from Investments | - R$ 745.38 M |
| Financing Cash Flow | - R$ 2.06 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 120.49 M |
| Updated 11/12/2024 | |
| Operating Cash Flow | R$ 723.78 M |
| Cash Flow from Investments | R$ 513.12 M |
| Financing Cash Flow | - R$ 1.17 B |
| Increase (Reduction) in Cash and Equivalents | R$ 69.16 M |
| Updated 11/12/2024 | |
Experimental - HAPV3
| CAPEX 3 months | - R$ 91.89 M |
| Free Cash Flow 3 months | R$ 631.90 M |
| CAPEX 12 months | - R$ 148.67 M |
| Free Cash Flow 12 months | R$ 2.54 B |
| Updated 11/12/2024 | |